FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Hamas agrees to complete disarmament under ‘historic’ Gaza agreement: Trump

Schiff-backed candidate abruptly ends gubernatorial campaign amid rumblings of a damaging report

Watch: Chuck Schumer Gets in Shouting Match with Heckler During News Conference

Trump Announces Plan to Replace Illegal Alien Truckers with American Veterans

Trump promotes Freedom Haulers Initiative to fast-track military veterans into trucking jobs

Virginia university report finds officials did not disclose student’s terror conviction

Watch: Eagles Defensive Coordinator Repeatedly Mocks Fauci During News Conference

House panel demands classified briefings on noncitizen voting, alleged Chinese election interference

Georgia mother fights off alleged child snatcher with gas pump in surveillance video

Watch: Mamdani Is Open to Forcing New Yorkers to Pay Cash Reparations for Slavery, Says ‘We Were Very Complicit’

War powers resolution fails as Senate Republicans stand by Trump on Iran

Thousands of migrants bull-rush Spanish border, sparking ‘total humanitarian and social emergency’

Florida AG threatens Fauci investigation after Senate hearing

Alex Murdaugh murder trial ‘egg juror’ fights to unseal state investigation into Becky Hill: report

Bryan Kohberger appointed new lawyer after Idaho murders case costs taxpayers over $8 million

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”